Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the safety and effectiveness of F-GYN, a sterile injectable medical device containing non-crosslinked hyaluronic acid, in adult women experiencing moderate to severe vaginal dryness and symptoms related to vaginal and vestibular atrophy. These conditions can cause discomfort, itching, burning, pain during sexual intercourse, reduced lubrication, and impact quality of life. The study compares F-GYN injection to standard non-hormonal symptomatic care to see if it improves vaginal health. Participants will be randomly assigned to one of two groups the study group will receive a single F-GYN injection at the start of the study, while the control group will continue their usual non-hormonal care for 4 weeks before receiving the F-GYN injection. The injection is given by a qualified gynecologist into vaginal and vestibular tissues. After injection, participants will be followed for up to 6 months with clinical assessments and questionnaires. During the study, participants will attend visits for gynecological exams and complete questionnaires about symptoms like vaginal dryness, itching, burning, pain during intercourse, sexual comfort, and quality of life. Safety will be monitored by collecting any adverse events throughout the follow-up period. The primary outcome is the change in vaginal health measured by the Vaginal Health Index after 4 weeks. Additional assessments will continue up to 6 months after injection.